Your browser doesn't support javascript.
loading
Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma.
Tonner, Henrik; Hunn, Selina; Auler, Nadine; Schmelter, Carsten; Pfeiffer, Norbert; Grus, Franz H.
Afiliação
  • Tonner H; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Hunn S; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Auler N; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Schmelter C; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Pfeiffer N; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
  • Grus FH; Department of Experimental Ophthalmology, University Medical Center, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Int J Mol Sci ; 23(21)2022 Nov 07.
Article em En | MEDLINE | ID: mdl-36362420

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma Idioma: En Ano de publicação: 2022 Tipo de documento: Article